
Learning from BTK Inhibitors & Moving Forward the Therapeutic Field in CLL
William G. Wierda, MD, PhD

Learning from BTK Inhibitors & Moving Forward the Therapeutic Field in CLL
William G. Wierda, MD, PhD

CAR T Cell Therapies in Lymphoid Malignancies: Here to Stay!
Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

CAR T Cell Therapies in Lymphoid Malignancies: Here to Stay!
Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

Management of Side Effects of Soome Common Targeted Therapies (ALK/BTK/IDH 1/2 Inbibitors
Paola Izquierdo, ARNP, BSN, FNP-BC